ATC Group: A02BC02 Pantoprazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BC02 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Proton pump inhibitors
5
A02BC02
Pantoprazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
40 mg
PAREN - Parenteral
40 mg

Active ingredients in A02BC02

Active Ingredient
Description

Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells.

Medicines in this ATC group

Drug
Countries

New Zealand

Estonia Lithuania

Hong Kong Singapore

Estonia Lithuania

South Africa

Ecuador

Ecuador

South Africa

Poland

Austria Cyprus Estonia Ireland Lithuania ...

Brazil

Singapore

Cyprus

Hong Kong

Ecuador

South Africa

Austria Italy

Brazil

Poland

Brazil

Estonia France Lithuania

South Africa

Poland

Austria Estonia Ireland Italy Lithuania ...

Australia

Estonia Lithuania Poland

Poland

Singapore

South Africa

Lithuania

Hong Kong Poland

Ecuador

Hong Kong

Estonia Italy Lithuania Spain

Australia

Singapore

Austria

Ireland

Estonia Lithuania

Hong Kong

Brazil Ecuador

Ecuador South Africa

Cyprus Ireland

Austria Canada Estonia Hong Kong Lithuania ...

Singapore South Africa

South Africa

Hong Kong South Africa

Germany Italy

Hong Kong

Austria Brazil Ecuador Estonia Germany ...

Estonia Lithuania

Ireland

Estonia Lithuania

Poland

Singapore

New Zealand

Hong Kong

Tunisia

South Africa

South Africa

Italy Singapore South Africa

Hong Kong

Hong Kong

South Africa

South Africa

South Africa

South Africa

Brazil

South Africa

Ireland United Kingdom

Brazil

Poland

Tunisia

Cyprus

Germany

Australia

Australia Austria Estonia Finland Ireland ...

Australia

Brazil Canada Ecuador Hong Kong

South Africa

Hong Kong

South Africa

Hong Kong

Lithuania

South Africa

Hong Kong

South Africa

Hong Kong

Brazil

Austria Ecuador

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
IE
Summary of Product Characteristics (SPC)
IE
Summary of Product Characteristics (SPC)
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
Structured Product Monograph (SPM)
CA